Prevalence of JAK-2 mutations in patients with abdominal venous thromboses

Prevalence of JAK-2 mutations in patients with abdominal venous thromboses - JAK2 MV

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026943

Enrollment

100

Registered

2021-10-28

Start date

2017-02-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I81 K55.0 I82.0 I82.2 I82.3 I82.80 I82.88

Interventions

Group 1: - single blood sample (5ml)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with thrombosis of any age in the portal vein, hepatic vein, spleen vein, mesenterial vein or other abdominal veins - Detection of thrombosis by imaging (sonography, CT, MRI) or surgery

Exclusion criteria

Exclusion criteria: <18 years

Design outcomes

Primary

Measure	Time frame
Detection of JAK2 Mutation	—

Secondary

Measure	Time frame
Detection of further Mutation	—

Countries

Germany

Contacts

Public ContactLarissa Henze

Universitätsmedizin Rostock Zentrum für Innere Medizin III Hämatologie, Onkologie, Palliativmedizin

klinischestudien@med.uni-rostock.de+49 381 494 7459

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026